Popular heartburn drug ranitidine recalled: What you need to know and do

If you or a family member take ranitidine (Zantac) to relieve heartburn, you may have heard that the FDA has found a probable human carcinogen (a substance that could cause cancer) in it. The story is unfolding quickly and many details remain murky. Here is what we know so far and what you should do. What do we know so far? On September 13, 2019, the FDA announced that preliminary tests found low levels of N-nitrosodimethylamine (NDMA) in ranitidine, a heartburn medication used by millions of Americans. This week, the drug companies Novartis (through its generic division, Sandoz) and Apotex announced that they were recalling all of their generic ranitidine products sold in the US. These announcements came after a Connecticut-based online pharmacy informed the FDA that

From http://besthealthnews.com/2019/09/popular-heartburn-drug-ranitidine-recalled-what-you-need-to-know-and-do/?utm_source=rss&utm_medium=rss&utm_campaign=popular-heartburn-drug-ranitidine-recalled-what-you-need-to-know-and-do

from
https://healthnews010.wordpress.com/2019/09/29/popular-heartburn-drug-ranitidine-recalled-what-you-need-to-know-and-do/